Thursday, October 30, 2014

18:00-19:15 Opening Session 

Keynote speaker and prize ceremony

19:15-20:30 Networking reception

 

Friday , October 31, 2014

  Hall A Hall B
08:30-10:30

Plenary Session I:

Screening for thrombophilia and pregnancy complications

 
10:30-11:00 Coffee break and poster viewing
11:00-13:00

Parallel Session II:

Heparin, Warfarin and novel anticoagulants

Parallel Session III:

Epidemiology and risk factors of venous thrombosis in children

13:00-14:00 Lunch break and poster viewing
14:00-16:00

Plenary Session IV:

Hemophilia care: Current guidelines and applications of new factor concentrates 
 
16:00-16:30 Coffee break and poster viewing 
16:30-18:30

Parallel Session V:

Antiplatelet therapy and monitoring

Parallel Session VI:

Replacement therapy before surgery of FVII & FXI deficient patients

 

Saturday, November 1, 2014

  Hall A Hall B
08:30-10:00

 

Industry Symposium
Session not included in main CME/CPD credit program
For more information, click here

 
10:00-10:30 Coffee break and poster viewing
10:30-12:30

Parallel Session VII:

Pharmacogenomics; Thrombolytic therapy

Parallel Session VIII:

Heparins, warfarin and new anticoagulants for  pediatric venous thrombosis 

12:30-13:30 Lunch break and poster viewing
13:30-15:30

Plenary Session IX:

Immune thrombocytopenia; Bleeding complications of new oral anticoagulants

 
15:30-16:00 Coffee break and poster viewing 
16:00-18:00

Parallel Session X:

Primary prevention of venous thrombosis and coronary artery disease

Parallel Session XI:

Plasma derived versus recombinant factor VIII concentrates 

 

Thrombotic disorders and anti-thrombotics

Bleeding disorders

Pediatrics

Industry session